| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyotrophic Lateral Sclerosis | 29 | 2024 | 511 | 6.300 |
Why?
|
| RNA-Binding Protein FUS | 14 | 2023 | 53 | 5.340 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2024 | 162 | 1.570 |
Why?
|
| Mutation | 19 | 2024 | 2666 | 1.540 |
Why?
|
| Nuclear Pore Complex Proteins | 2 | 2023 | 27 | 1.450 |
Why?
|
| Neurodegenerative Diseases | 4 | 2024 | 149 | 1.430 |
Why?
|
| Profilins | 4 | 2024 | 45 | 1.420 |
Why?
|
| Superoxide Dismutase | 7 | 2022 | 221 | 1.380 |
Why?
|
| Frontotemporal Dementia | 6 | 2023 | 157 | 1.340 |
Why?
|
| Motor Neurons | 7 | 2022 | 213 | 1.290 |
Why?
|
| Stress, Physiological | 3 | 2019 | 208 | 1.220 |
Why?
|
| Brain Injuries, Traumatic | 4 | 2023 | 93 | 1.180 |
Why?
|
| Cytoplasmic Granules | 4 | 2019 | 53 | 1.060 |
Why?
|
| Active Transport, Cell Nucleus | 3 | 2023 | 114 | 1.000 |
Why?
|
| Neurons | 10 | 2023 | 941 | 0.940 |
Why?
|
| Superoxide Dismutase-1 | 9 | 2022 | 144 | 0.900 |
Why?
|
| Microglia | 3 | 2024 | 252 | 0.850 |
Why?
|
| Skull | 1 | 2023 | 52 | 0.780 |
Why?
|
| Single-Domain Antibodies | 1 | 2022 | 21 | 0.760 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2023 | 86 | 0.760 |
Why?
|
| Protein Folding | 9 | 2022 | 269 | 0.740 |
Why?
|
| Polymerization | 1 | 2021 | 35 | 0.690 |
Why?
|
| Axonal Transport | 3 | 2017 | 32 | 0.690 |
Why?
|
| Actins | 2 | 2021 | 262 | 0.640 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 664 | 0.620 |
Why?
|
| Golgi Apparatus | 1 | 2019 | 65 | 0.590 |
Why?
|
| Receptors, AMPA | 1 | 2019 | 42 | 0.590 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2017 | 150 | 0.590 |
Why?
|
| Animals | 26 | 2023 | 21248 | 0.580 |
Why?
|
| Glutamic Acid | 1 | 2019 | 103 | 0.570 |
Why?
|
| Cell Nucleus | 4 | 2019 | 632 | 0.570 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 178 | 0.550 |
Why?
|
| Humans | 45 | 2026 | 64726 | 0.530 |
Why?
|
| Mice | 19 | 2023 | 11062 | 0.520 |
Why?
|
| Proteostasis Deficiencies | 2 | 2021 | 6 | 0.510 |
Why?
|
| Cyclophilin A | 2 | 2010 | 34 | 0.500 |
Why?
|
| Protein Biosynthesis | 1 | 2019 | 331 | 0.500 |
Why?
|
| Oxidative Stress | 4 | 2013 | 317 | 0.480 |
Why?
|
| Calcium | 2 | 2019 | 583 | 0.480 |
Why?
|
| Epitopes | 2 | 2026 | 292 | 0.450 |
Why?
|
| Cells | 1 | 2014 | 32 | 0.430 |
Why?
|
| Cytoplasm | 5 | 2023 | 282 | 0.420 |
Why?
|
| Hypertonic Solutions | 1 | 2013 | 3 | 0.410 |
Why?
|
| RNA, Messenger | 2 | 2019 | 1573 | 0.400 |
Why?
|
| DNA Repair | 1 | 2014 | 251 | 0.370 |
Why?
|
| Cell Line | 6 | 2018 | 2036 | 0.370 |
Why?
|
| Mutant Proteins | 4 | 2021 | 105 | 0.360 |
Why?
|
| HIV-1 | 2 | 2010 | 704 | 0.350 |
Why?
|
| Autoantibodies | 1 | 2011 | 184 | 0.330 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1027 | 0.320 |
Why?
|
| Brain | 7 | 2023 | 1598 | 0.320 |
Why?
|
| alpha-Synuclein | 3 | 2026 | 38 | 0.310 |
Why?
|
| Capsid Proteins | 1 | 2010 | 105 | 0.300 |
Why?
|
| Spinal Cord | 5 | 2018 | 208 | 0.290 |
Why?
|
| Protein Conformation | 5 | 2015 | 790 | 0.270 |
Why?
|
| C9orf72 Protein | 3 | 2023 | 114 | 0.260 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 333 | 0.260 |
Why?
|
| Antibodies, Monoclonal | 2 | 2026 | 876 | 0.250 |
Why?
|
| Oxidation-Reduction | 5 | 2018 | 323 | 0.250 |
Why?
|
| HeLa Cells | 2 | 2021 | 540 | 0.250 |
Why?
|
| Lewy Body Disease | 1 | 2006 | 15 | 0.240 |
Why?
|
| Single-Chain Antibodies | 1 | 2026 | 5 | 0.240 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2019 | 103 | 0.240 |
Why?
|
| Cholesterol | 2 | 2006 | 260 | 0.230 |
Why?
|
| Crystallography, X-Ray | 3 | 2015 | 419 | 0.220 |
Why?
|
| Proteomics | 2 | 2019 | 290 | 0.220 |
Why?
|
| Pick Disease of the Brain | 1 | 2023 | 6 | 0.210 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 2256 | 0.200 |
Why?
|
| Models, Molecular | 6 | 2012 | 1158 | 0.200 |
Why?
|
| Proteins | 3 | 2015 | 762 | 0.200 |
Why?
|
| Intravital Microscopy | 1 | 2023 | 13 | 0.200 |
Why?
|
| Cysteine | 2 | 2014 | 107 | 0.200 |
Why?
|
| Brain Concussion | 1 | 2023 | 37 | 0.200 |
Why?
|
| Neuronal Outgrowth | 1 | 2022 | 9 | 0.190 |
Why?
|
| Coloring Agents | 1 | 2023 | 51 | 0.190 |
Why?
|
| Cytophagocytosis | 1 | 2022 | 2 | 0.190 |
Why?
|
| Head | 1 | 2023 | 56 | 0.190 |
Why?
|
| Synaptosomes | 1 | 2022 | 16 | 0.190 |
Why?
|
| Mass Spectrometry | 3 | 2014 | 294 | 0.190 |
Why?
|
| Autophagy | 2 | 2015 | 233 | 0.190 |
Why?
|
| Recombinant Proteins | 3 | 2014 | 710 | 0.180 |
Why?
|
| Chronic Traumatic Encephalopathy | 1 | 2021 | 5 | 0.170 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2021 | 22 | 0.170 |
Why?
|
| Tauopathies | 1 | 2021 | 17 | 0.170 |
Why?
|
| Capsid | 1 | 2002 | 102 | 0.170 |
Why?
|
| Phagocytosis | 1 | 2022 | 266 | 0.170 |
Why?
|
| DNA Repeat Expansion | 2 | 2023 | 58 | 0.160 |
Why?
|
| Superoxides | 1 | 2020 | 73 | 0.160 |
Why?
|
| Animals, Genetically Modified | 1 | 2021 | 310 | 0.160 |
Why?
|
| Cell Differentiation | 2 | 2022 | 1380 | 0.160 |
Why?
|
| Decapodiformes | 2 | 2017 | 14 | 0.150 |
Why?
|
| Coat Protein Complex I | 1 | 2019 | 5 | 0.150 |
Why?
|
| Arsenites | 1 | 2019 | 7 | 0.150 |
Why?
|
| Weight Loss | 1 | 2021 | 274 | 0.150 |
Why?
|
| Phenotype | 2 | 2021 | 1233 | 0.150 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2018 | 26 | 0.140 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 1557 | 0.140 |
Why?
|
| Mutation, Missense | 2 | 2010 | 190 | 0.140 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2010 | 84 | 0.140 |
Why?
|
| Nipples | 1 | 2018 | 12 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 347 | 0.140 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2018 | 51 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 676 | 0.140 |
Why?
|
| Drosophila | 1 | 2021 | 481 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2012 | 744 | 0.130 |
Why?
|
| Amino Acid Sequence | 6 | 2026 | 1592 | 0.130 |
Why?
|
| Preoperative Care | 1 | 2018 | 198 | 0.130 |
Why?
|
| Male | 11 | 2023 | 30787 | 0.130 |
Why?
|
| Protein Binding | 3 | 2014 | 1637 | 0.120 |
Why?
|
| Isoenzymes | 2 | 2014 | 129 | 0.120 |
Why?
|
| Kinetics | 3 | 2010 | 758 | 0.120 |
Why?
|
| Astrocytes | 3 | 2022 | 121 | 0.120 |
Why?
|
| Phenylbutyrates | 1 | 2015 | 6 | 0.120 |
Why?
|
| Haloperidol | 1 | 2015 | 15 | 0.120 |
Why?
|
| Dipeptides | 1 | 2015 | 68 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 235 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2014 | 251 | 0.110 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2015 | 37 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2015 | 57 | 0.110 |
Why?
|
| M Phase Cell Cycle Checkpoints | 1 | 2014 | 4 | 0.110 |
Why?
|
| Phosphorylation | 2 | 2014 | 961 | 0.110 |
Why?
|
| Hybridomas | 1 | 2014 | 63 | 0.110 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 80 | 0.110 |
Why?
|
| Genetic Association Studies | 2 | 2014 | 122 | 0.110 |
Why?
|
| Gene Expression | 2 | 2014 | 855 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 203 | 0.100 |
Why?
|
| In Vitro Techniques | 2 | 2015 | 494 | 0.100 |
Why?
|
| Adult | 6 | 2018 | 17234 | 0.100 |
Why?
|
| Escherichia coli | 2 | 2014 | 707 | 0.100 |
Why?
|
| Sorbitol | 1 | 2013 | 2 | 0.100 |
Why?
|
| Protein Structure, Secondary | 1 | 2014 | 260 | 0.100 |
Why?
|
| Methylation | 1 | 2013 | 129 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2011 | 363 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 236 | 0.100 |
Why?
|
| Nerve Degeneration | 1 | 2013 | 72 | 0.100 |
Why?
|
| Middle Aged | 5 | 2018 | 18108 | 0.100 |
Why?
|
| Female | 9 | 2023 | 33747 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2013 | 610 | 0.090 |
Why?
|
| Cell Death | 1 | 2013 | 288 | 0.090 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2013 | 178 | 0.090 |
Why?
|
| Survival | 1 | 2011 | 11 | 0.090 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 1281 | 0.090 |
Why?
|
| Cell Survival | 1 | 2013 | 579 | 0.090 |
Why?
|
| Transduction, Genetic | 1 | 2013 | 242 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2013 | 620 | 0.090 |
Why?
|
| Histones | 1 | 2014 | 494 | 0.090 |
Why?
|
| Microscopy, Electron | 2 | 2015 | 253 | 0.090 |
Why?
|
| RNA Interference | 1 | 2014 | 640 | 0.090 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2010 | 34 | 0.080 |
Why?
|
| Epitope Mapping | 1 | 2010 | 52 | 0.080 |
Why?
|
| Esterases | 1 | 2010 | 13 | 0.080 |
Why?
|
| Models, Biological | 3 | 2010 | 1198 | 0.080 |
Why?
|
| Aryldialkylphosphatase | 1 | 2010 | 19 | 0.080 |
Why?
|
| Catalytic Domain | 1 | 2010 | 200 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2010 | 336 | 0.080 |
Why?
|
| DNA Helicases | 1 | 2011 | 198 | 0.080 |
Why?
|
| Stereoisomerism | 2 | 2015 | 52 | 0.070 |
Why?
|
| Trans-Activators | 1 | 2011 | 321 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2009 | 24 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 1216 | 0.070 |
Why?
|
| Insulin | 1 | 2013 | 692 | 0.070 |
Why?
|
| Hydrogen Bonding | 1 | 2009 | 128 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 3452 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 374 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 2239 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 366 | 0.070 |
Why?
|
| Axons | 2 | 2023 | 125 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 968 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 630 | 0.070 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2007 | 21 | 0.060 |
Why?
|
| Zebrafish | 1 | 2010 | 372 | 0.060 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2011 | 449 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 572 | 0.060 |
Why?
|
| Catalysis | 2 | 2007 | 164 | 0.060 |
Why?
|
| Dopamine | 1 | 2006 | 106 | 0.060 |
Why?
|
| Proteome | 1 | 2026 | 151 | 0.060 |
Why?
|
| Armadillo Domain Proteins | 1 | 2023 | 27 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2026 | 312 | 0.050 |
Why?
|
| Cerebral Cortex | 2 | 2015 | 267 | 0.050 |
Why?
|
| Aged | 3 | 2018 | 14838 | 0.050 |
Why?
|
| Biological Assay | 1 | 2022 | 57 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2023 | 204 | 0.050 |
Why?
|
| Polyphosphates | 1 | 2022 | 13 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2022 | 53 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2014 | 269 | 0.050 |
Why?
|
| Reflex | 1 | 2021 | 27 | 0.040 |
Why?
|
| Virulence | 1 | 2002 | 200 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2023 | 1219 | 0.040 |
Why?
|
| Models, Chemical | 1 | 2002 | 135 | 0.040 |
Why?
|
| Head Injuries, Closed | 1 | 2021 | 18 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2002 | 277 | 0.040 |
Why?
|
| Cations, Monovalent | 1 | 2000 | 1 | 0.040 |
Why?
|
| IMP Dehydrogenase | 1 | 2000 | 9 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2011 | 198 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2184 | 0.040 |
Why?
|
| Tunicamycin | 1 | 2018 | 8 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2023 | 2148 | 0.040 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2018 | 20 | 0.040 |
Why?
|
| Transfection | 1 | 2020 | 701 | 0.040 |
Why?
|
| Time Factors | 1 | 2006 | 3744 | 0.040 |
Why?
|
| Proteostasis | 1 | 2018 | 11 | 0.040 |
Why?
|
| Tryptophan | 1 | 2018 | 53 | 0.040 |
Why?
|
| RNA | 2 | 2014 | 426 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 498 | 0.030 |
Why?
|
| Gene Editing | 1 | 2022 | 328 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 1984 | 0.030 |
Why?
|
| Meglumine | 1 | 2018 | 21 | 0.030 |
Why?
|
| Peptides | 1 | 2002 | 587 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 2018 | 71 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 60 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 1633 | 0.030 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2015 | 19 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2002 | 903 | 0.030 |
Why?
|
| Contrast Media | 1 | 2018 | 429 | 0.030 |
Why?
|
| Patient Selection | 1 | 2018 | 483 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 1159 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1210 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 80 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 372 | 0.030 |
Why?
|
| Disulfides | 1 | 2014 | 66 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 675 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 82 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2015 | 435 | 0.020 |
Why?
|
| Artifacts | 1 | 2014 | 125 | 0.020 |
Why?
|
| HLA-DRB1 Chains | 1 | 2013 | 16 | 0.020 |
Why?
|
| Cell Movement | 1 | 2015 | 474 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 430 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2013 | 62 | 0.020 |
Why?
|
| Jews | 1 | 2012 | 10 | 0.020 |
Why?
|
| Growth Cones | 1 | 2012 | 14 | 0.020 |
Why?
|
| Aging | 1 | 2018 | 763 | 0.020 |
Why?
|
| Leukocytes | 1 | 2013 | 105 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2015 | 3140 | 0.020 |
Why?
|
| Exome | 1 | 2012 | 78 | 0.020 |
Why?
|
| Pancreas | 1 | 2013 | 154 | 0.020 |
Why?
|
| Pedigree | 1 | 2012 | 198 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 118 | 0.020 |
Why?
|
| Immune System | 1 | 2013 | 131 | 0.020 |
Why?
|
| Oxygen | 1 | 2013 | 315 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 512 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 1580 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 193 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 401 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 902 | 0.020 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2011 | 18 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2013 | 244 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 491 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 316 | 0.020 |
Why?
|
| RNA Helicases | 1 | 2011 | 98 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2013 | 326 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2009 | 116 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 705 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2009 | 195 | 0.020 |
Why?
|
| Age of Onset | 1 | 2009 | 173 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2011 | 397 | 0.020 |
Why?
|
| tau Proteins | 1 | 2009 | 207 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 237 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2009 | 314 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 1327 | 0.020 |
Why?
|
| Liver | 1 | 2013 | 866 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 5571 | 0.020 |
Why?
|
| Family | 1 | 2010 | 245 | 0.020 |
Why?
|
| Exons | 1 | 2009 | 207 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2009 | 187 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2009 | 278 | 0.020 |
Why?
|
| Synapses | 1 | 2009 | 192 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2009 | 318 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 417 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 2007 | 11 | 0.020 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2007 | 5 | 0.020 |
Why?
|
| Titrimetry | 1 | 2007 | 11 | 0.020 |
Why?
|
| Aldehydes | 1 | 2006 | 13 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2007 | 114 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 67 | 0.020 |
Why?
|
| Amyloid | 1 | 2006 | 71 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 6799 | 0.010 |
Why?
|
| Biopolymers | 1 | 2006 | 72 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2006 | 158 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 5755 | 0.010 |
Why?
|
| Inosine Monophosphate | 1 | 2000 | 3 | 0.010 |
Why?
|
| Lithium | 1 | 2000 | 21 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2000 | 97 | 0.010 |
Why?
|
| Sodium | 1 | 2000 | 60 | 0.010 |
Why?
|
| Magnesium | 1 | 2000 | 54 | 0.010 |
Why?
|
| Potassium | 1 | 2000 | 97 | 0.010 |
Why?
|
| NAD | 1 | 2000 | 53 | 0.010 |
Why?
|
| Inflammation | 1 | 2006 | 1180 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2000 | 388 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2006 | 763 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 850 | 0.010 |
Why?
|
| Binding Sites | 1 | 2000 | 920 | 0.010 |
Why?
|